Guardant Health Inc (NAS:GH)
$ 29.54 0 (0%) Market Cap: 3.61 Bil Enterprise Value: 3.83 Bil PE Ratio: 0 PB Ratio: 52.66 GF Score: 70/100

Guardant Health Inc at Goldman Sachs Healthcare Conference Transcript

Jun 12, 2023 / 11:00PM GMT
Release Date Price: $34.73 (+5.69%)
Matthew Carlisle Sykes
Goldman Sachs Group, Inc., Research Division - Research Analyst

Thanks, everybody, for joining. Good afternoon, I'm Matt Sykes covers life sciences tools and diagnostics at Goldman Sachs. I have the pleasure of welcoming the Guardant Health management team here today. To my right is Helmy Eltoukhy, Co-Founder, Co-CEO; AmirAli Talasaz, Co-Founder, Co-CEO; and Mike Bell, the CFO. Thank you, guys, for joining today. Thanks for coming down.

Unidentified Company Representative

Appreciate it.

Questions & Answers

Matthew Carlisle Sykes
Goldman Sachs Group, Inc., Research Division - Research Analyst

Maybe if you could just help us kind of set the stage first. Talk about some of the more recent results you've had and what trends you're seeing in your business as we enter into the second half of this year?

Helmy Eltoukhy
Guardant Health, Inc. - Co-Founder, Co-CEO & Chairman

Yes. No. I mean we're really pleased in terms of how we started the year.

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot